Guillain-Barré syndrome following receipt of influenza A (H1N1) 2009 monovalent vaccine in Korea with an emphasis on Brighton Collaboration case definition

Vaccine

Volumn 29, Issue 11, 2011, Pages 2066-2070

  Choe, Young June ^a   Cho, Heeyeon ^a   Bae, Geun Ryang ^a   Lee, Jong Koo ^b  

^a Division of Vaccine Preventable Disease Control   (South Korea)

^b Korea Centers for Disease Control and Prevention   (South Korea)

Author keywords

Adverse event; Brighton Collaboration; Case definition; Fisher syndrome; Guillain Barre syndrome; Influenza; Vaccination

Indexed keywords

INFLUENZA VACCINE;

ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; CLINICAL ARTICLE; DISEASE ASSOCIATION; FEMALE; GUILLAIN BARRE SYNDROME; HEALTH PROGRAM; HUMAN; INFANT; INFECTION PREVENTION; INFLUENZA A (H1N1); KOREA; MALE; MASS IMMUNIZATION; MEDICAL RECORD REVIEW; MEDICAL SOCIETY; PRESCHOOL CHILD; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SCHOOL CHILD; TOTAL QUALITY MANAGEMENT;

ADOLESCENT; ADULT; ADVERSE DRUG REACTION REPORTING SYSTEMS; AGED; CHILD; CHILD, PRESCHOOL; FEMALE; GUILLAIN-BARRE SYNDROME; HUMANS; INFANT; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA VACCINES; MALE; MIDDLE AGED; MILLER FISHER SYNDROME; REPUBLIC OF KOREA; RETROSPECTIVE STUDIES; VACCINATION; YOUNG ADULT;

EID: 79951812982     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2011.01.007     Document Type: Article

References (28)

1. Schonberger L.B., Bregman D.J., Sullivan-Bolyai J.Z., et al. Guillain-Barre syndrome following vaccination in the National Influenza Immunization Program, United States, 1976-1977. Am J Epidemiol 1979, 110:105-123.
2. Kaplan J.E., Katona P., Hurwitz E.S., Schonberger L.B. Guillain-Barre syndrome in the United States, 1979-1980 and 1980-1981, Lack of an association with influenza vaccination. JAMA 1982, 248:698-700.
3. Safranek T.J., Lawrence D.N., Kurland L.T., et al. Reassessment of the association between Guillain-Barre syndrome and receipt of swine influenza vaccine in 1976-1977: results of a two-state study, Expert Neurology Group. Am J Epidemiol 1991, 133:940-951.
4. Haber P., DeStefano F., Angulo F.J., et al. Guillain-Barre syndrome following influenza vaccination. JAMA 2004, 292:2478-2481.
5. Girard M.P., Tam J.S., Assossou O.M., Kieny M.P. The 2009 A (H1N1) influenza virus pandemic: a review. Vaccine 2010, 28:4895-4902.
6. Sander B., Bauch C.T., Fisman D., et al. Is a mass immunization program for pandemic (H1N1) 2009 good value for money? Evidence from the Canadian Experience. Vaccine 2010, 28:6210-6220.
7. Bonhoeffer J., Bentsi-Enchill A., Chen R.T., et al. Guidelines for collection, analysis and presentation of vaccine safety data in surveillance systems. Vaccine 2009, 27:2289-2297.
8. Preliminary results: surveillance for Guillain-Barre syndrome after receipt of influenza A (H1N1) 2009 monovalent vaccine-United States, 2009-2010. MMWR Morb Mortal Wkly Rep 2010, 59:657-661.
9. Bonhoeffer J., Kohl K., Chen R., et al. The Brighton siva: addressing the need for standardized case definitions of adverse events following immunization (AEFI). Vaccine 2002, 21:298-302.
10. Sejvar J.J., Kohl K.S., Gidudu J., et al. Guillain-Barre syndrome and Fisher syndrome: case definitions and guidelines for collection, analysis, and presentation of immunization safety data. Vaccine 2010, 10.1016/j.vaccine.2010.06.003.
11. Sohn Y.M. Japanese encephalitis immunization in South Korea: past, present, and future. Emerg Infect Dis 2000, 6:17-24.
12. Kim J.S., Jo D.S., Go U., Park B.H., Cho H., Oh D.K. National vaccine injury compensation program in Korea: a 12-year experience. Pediatrics 2008, 121.
13. Jefferson T., Di Pietrantonj C., Rivetti A., Bawazeer G.A., Al-Ansary L.A., Ferroni E. Vaccines for preventing influenza in healthy adults. Cochrane Database Syst Rev 2010, 7:CD001269.
14. Burwen D.R., Ball R., Bryan W.W., et al. Evaluation of Guillain-Barre Syndrome among recipients of influenza vaccine in 2000 and 2001. Am J Prev Med 2010, 39:296-304.
15. Ropper A.H. The Guillain-Barre syndrome. N Engl J Med 1992, 326:1130-1136.
16. Hughes R.A., Cornblath D.R. Guillain-Barre syndrome. Lancet 2005, 366:1653-1666.
17. McGrogan A., Madle G.C., Seaman H.E., de Vries C.S. The epidemiology of Guillain-Barre syndrome worldwide. A systematic literature review. Neuroepidemiology 2009, 32:150-163.
18. Landaverde J.M., Danovaro-Holliday M.C., Trumbo S.P., Pacis-Tirso C.L., Ruiz-Matus C. Guillain-Barre syndrome in children aged <15 years in Latin America and the Caribbean: baseline rates in the context of the influenza A (H1N1) pandemic. J Infect Dis 2010, 201:746-750.
19. Dias-Tosta E., Kuckelhaus C.S. Guillain-Barre syndrome in a population less than 15 years old in Brazil. Arq Neuropsiquiatr 2002, 60:367-373.
20. Black S., Eskola J., Siegrist C.A., et al. Importance of background rates of disease in assessment of vaccine safety during mass immunisation with pandemic H1N1 influenza vaccines. Lancet 2009, 374:2115-2122.
21. Iskander J., Haber P., Herrera G. Monitoring vaccine safety during an influenza pandemic. Yale J Biol Med 2005, 78:265-275.
22. Iskander J., Broder K. Monitoring the safety of annual and pandemic influenza vaccines: lessons from the US experience. Expert Rev Vaccines 2008, 7:75-82.
23. De Wals P. Does informing patients of the risk of acquiring Guillain-Barre syndrome following influenza vaccination have an effect on their willingness to be vaccinated?. Can Commun Dis Rep 2000, 26:205-207.
24. Vellozzi C., Broder K.R., Haber P., et al. Adverse events following influenza A (H1N1) 2009 monovalent vaccines reported to the vaccine adverse events reporting system, United States, October 1, 2009-January 31, 2010. Vaccine 2010.
25. Safety of influenza A (H1N1) 2009 monovalent vaccines-United States, October 1-November 24, 2009. MMWR Morb Mortal Wkly Rep 2009, 58:1351-1356.
26. Cho H.Y., Kim C.H., Go U.Y., Lee H.J. Immunization decision-making in the Republic of Korea: the structure and functioning of the Korea Advisory Committee on Immunization Practices. Vaccine 2010, 28(Suppl. 1):A91-A95.
27. Stowe J., Andrews N., Wise L., Miller E. Investigation of the temporal association of Guillain-Barre syndrome with influenza vaccine and influenza like illness using the United Kingdom General Practice Research Database. Am J Epidemiol 2009, 169:382-388.
28. Hicks C.W., Kay B., Worley S.E., Moodley M. A clinical picture of Guillain-Barre syndrome in children in the United States. J Child Neurol 2010.